<?xml version="1.0" encoding="UTF-8"?>
<p>Antibiotic therapy is indicated for faster symptom resolution as well as eliminating and/or limiting the spread of the disease from person-to-person [
 <xref rid="B4-antibiotics-09-00909" ref-type="bibr">4</xref>,
 <xref rid="B17-antibiotics-09-00909" ref-type="bibr">17</xref>,
 <xref rid="B21-antibiotics-09-00909" ref-type="bibr">21</xref>]. In Australia, mild and moderate impetigo forms are usually treated with topical antibiotics (i.e., mupirocin) whereas severe or recurrent infections, are treated with oral antibiotics (i.e., dicloxacillin, flucloxacillin, cefalexin, and trimethoprim/sulfamethoxazole [co-trimoxazole]) [
 <xref rid="B42-antibiotics-09-00909" ref-type="bibr">42</xref>]. Several systematic reviews also suggest topical antibiotics as the treatment of choice for impetigo and systemic antibiotics for complicated impetigo with extensive infections [
 <xref rid="B13-antibiotics-09-00909" ref-type="bibr">13</xref>,
 <xref rid="B17-antibiotics-09-00909" ref-type="bibr">17</xref>,
 <xref rid="B43-antibiotics-09-00909" ref-type="bibr">43</xref>,
 <xref rid="B44-antibiotics-09-00909" ref-type="bibr">44</xref>]. However, there is a lack of clear conclusive evidence regarding the difference in clinical efficacy between topical and systemic antibiotics for impetigo [
 <xref rid="B13-antibiotics-09-00909" ref-type="bibr">13</xref>]. A significant number of reports suggest that topical treatments may be superior or equivalent to the oral therapy even for treating extensive form of impetigo [
 <xref rid="B17-antibiotics-09-00909" ref-type="bibr">17</xref>,
 <xref rid="B21-antibiotics-09-00909" ref-type="bibr">21</xref>,
 <xref rid="B45-antibiotics-09-00909" ref-type="bibr">45</xref>,
 <xref rid="B46-antibiotics-09-00909" ref-type="bibr">46</xref>,
 <xref rid="B47-antibiotics-09-00909" ref-type="bibr">47</xref>,
 <xref rid="B48-antibiotics-09-00909" ref-type="bibr">48</xref>].
</p>
